Register now and get 2 months free trial on Discovery CORE!
Our software will help you to:
Take your research analysis to the next level by incorporating AI to analyse OCT data
Share data in a secure and collaborative way
Create and evaluate registries and real-world evidence databases
Carlos Ciller, Stefanos Apostolopoulos, Sandro De Zanet found RetinAI
Beginning of the development of RetinAI Discovery®, a first in-class data management platform integrated with AI modules
Start of large projects involving RetinAI Discoveryfor Research and Clinical Study support in EU
RetinAI Discovery is CE marked and a master collaboration agreement is signed with Novartis for Discovery Unity & Discovery for Clinical Trials
FDA clearance for RetinAI Discovery and expansion to new disease areas: diabetic retinopathy, diabetic macular edema, glaucoma, geographic atrophy
Ut leo rhoncus in etiam tellus id augue donec sollicitudin tincidunt sit tortor in interdum magna auctor amet dapibus vestibulum ut id viverra preti.